Overexpression of CD74 was reported in various cancers (stomach, kidney, lung and multiple myeloma), suggesting that it can serve as a prognostic factor, with higher CD74 values indicating tumor progression [10, 12–16, 32]. This evidence concerns the gene CD74 and AL amyloidosis.